国家卫健委紧急叫停两项手术

Core Viewpoints - The National Health Commission has issued notifications prohibiting the use of "jejunum-ileum anastomosis" for treating type 2 diabetes and "cervical deep lymphatic vessel/vein anastomosis" for treating Alzheimer's disease due to lack of sufficient evidence supporting their safety and efficacy [1][2]. Group 1: Jejunum-Ileum Anastomosis for Type 2 Diabetes - The National Health Commission assessed the use of "jejunum-ileum anastomosis" for type 2 diabetes and found it lacks theoretical support and high-quality evidence, leading to its prohibition [1]. - Local health authorities are required to ensure that medical institutions cease using this technique for diabetes treatment, with serious consequences for non-compliance [1]. Group 2: Cervical Deep Lymphatic Vessel/Vein Anastomosis for Alzheimer's Disease - The National Health Commission has identified that "cervical deep lymphatic vessel/vein anastomosis" is still in the early exploratory stage of clinical research, with unclear indications and contraindications, resulting in its prohibition for Alzheimer's treatment [2][3]. - Local health authorities must monitor and ensure that medical institutions stop using this technique, while also providing follow-up services for affected patients [3]. - The National Health Commission will consider re-evaluating the clinical application of this technique once sufficient preclinical research evidence is available [3].